2,500
Views
21
CrossRef citations to date
0
Altmetric
Research Papers

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus

, , , , , , , , , , , & show all
Pages 2197-2203 | Received 13 Nov 2015, Accepted 06 Mar 2016, Published online: 28 Apr 2016

References

  • Reilly ML, Schillie SF, Smith E, Poissant T, Vonderwahl CW, Gerard K, Baumgartner J, Mercedes L, Sweet K, Muleta D, et al. Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus. J Diabetes Sci Technol 2012; 6:858-66; PMID:22920812; http://dx.doi.org/10.1177/193229681200600417
  • Centers for Disease Control and Prevention (CDC). Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011; 60:1709-11; PMID:22189894
  • Thompson ND, Perz JF. Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol 2009; 3:283-88; http://dx.doi.org/10.1177/193229680900300208
  • CDC DVH - Viral Hepatitis Outbreak Information - Outbreaks Related to Healthcare 2008–2013 [article online]. Available from: http://www.cdc.gov/hepatitis/Outbreaks/HealthcareHepOutbreakTable.htm [Accessed 8 September 2014].
  • Duffell EF, Milne LM, Seng C, Young Y, Xavier S, King S, Shukla H, Ijaz S, Ramsay M, local incident teams. Five hepatitis B outbreaks in care homes in the UK associated with deficiencies in infection control practice in blood glucose monitoring. Epidemiol Infect 2011; 139:327-35; http://dx.doi.org/10.1017/S0950268810001007
  • De Schrijver K, Eurosurveillance editorial team. Hepatitis B transmission in care homes linked to blood glucose monitoring, Belgium and United States. Euro Surveill 2005; 10:E050317.1.
  • Lanini S, Puro V, Lauria FN, Fusco FM, Nisii C, Ippolito G. Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med 2009; 7:15; http://dx.doi.org/10.1186/1741-7015-7-15
  • Farkas K, Jermendy G. Transmission of hepatitis B infection during home blood glucose monitoring. Diabet Med 1997; 14(3):263; http://dx.doi.org/10.1002/(SICI)1096-9136(199703)14:3%3c263::AID-DIA342%3e3.0.CO;2-R
  • Czech Vaccinology Society [article online]. Available from: http://www.vakcinace.eu/ockovani-v-cr-ppl [Accessed 30 December 2014].
  • Public Health Agency of Canada. Canadian Immunization Guide. Part 4 Active Vaccines. Hepatitis B Vaccine [article online]. Ottowa: 2015, Public Health Agency of Canada. Available from: http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-hepb-eng.php [Accessed 20 February 2015].
  • Conseil Supérieur de la Santé. Vaccination contre l'hépatite B [article online]. 2013. Available from: http://www.health.belgium.be/filestore/4930389_FR/fiche_de_vaccination_hépatite_B_06032013.pdf [Accessed 30 December 2014].
  • Schillie SF, Spradling PR, Murphy TV. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature. Diabetes Care 2012; 35:2690-97; PMID:23173138; http://dx.doi.org/10.2337/dc12-0312
  • Fabrizi F, Dixit V, Martin P, Messa P. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients. Aliment Pharmacol Ther 2011; 33:815-21; PMID:21281319; http://dx.doi.org/10.1111/j.1365-2036.2011.04589.x
  • Alavian S-M, Tabatabaei SV. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature. Vaccine 2010; 28:3773-77; PMID:20371390; http://dx.doi.org/10.1016/j.vaccine.2010.03.038
  • Keating GM, Noble S. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 2003; 63:1021-51; PMID:12699402; http://dx.doi.org/10.2165/00003495-200363100-00006
  • Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008; 46:1078-84; PMID:18444828; http://dx.doi.org/10.1086/529197
  • Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007; 211:144-56; PMID:17200946; http://dx.doi.org/10.1002/path.2104
  • Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159-69; http://dx.doi.org/10.1016/j.vaccine.2005.08.105
  • Hoel T, Wolter JM, Schuerman LM. Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults. Eur J Emerg Med 2006; 13:67-71; PMID:16525231; http://dx.doi.org/10.1097/01.mej.0000184993.51799.ad
  • Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis 1999; 179:489-92; PMID:9878036; http://dx.doi.org/10.1086/314578
  • Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.org/10.1128/CVI.00131-10
  • Vermeiren APA, Hoebe CJPA, Dukers-Muijrers NHTM. High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. J Clin Virol 2013; 58:262-4; PMID:23895931; http://dx.doi.org/10.1016/j.jcv.2013.07.003
  • Shaw FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, Roehm RR Jr, Talley WS, Hadler SC. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989; 7:425-30; PMID:2530717; http://dx.doi.org/10.1016/0264-410X(89)90157-6
  • Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 Suppl 1:S62-9; PMID:20042775
  • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-70.
  • Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-12; PMID:19414839; http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00006
  • Thome RA, Awosika-Olumo D, Nielsen C, Khuwaja S, Scott J, Xing J, Drobeniuc J, Hu DJ, Turner C, Wafeeg T, et al. Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities. Vaccine 2011; 29(50):9160-20.
  • Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998; 17:873-90; PMID:9595617; http://dx.doi.org/10.1002/(SICI)1097-0258(19980430)17:8%3c873::AID-SIM779%3e3.0.CO;2-I
  • Hanna JN, Faoagali JL, Buda PJ, Sheridan JW. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children. J Paediatr Child Health 1997; 33:67-70; PMID:9069048; http://dx.doi.org/10.1111/j.1440-1754.1997.tb00994.x
  • Cui W, Sun C-M, Deng B-C, Liu P. Association of polymorphisms in the interleukin-4 gene with response to hepatitis B vaccine and susceptibility to hepatitis B virus infection: a meta-analysis. Gene 2013; 525:35-40; PMID:23651591; http://dx.doi.org/10.1016/j.gene.2013.04.065